Intelligent Biomaterials Protein Delivery Molecular Imprinting and Micropatterning Nicholas A. Peppas.

Slides:



Advertisements
Similar presentations
INTRA-NASAL DRUG DELIVERY SYSTEM
Advertisements

Pharmacology for Anesthesia I Introduction. What is a Drug?
HOW DO DRUGS GET INTO THE BODY?. WHY BE CONCERNED ABOUT HOW DRUGS GET INTO BODY? Bioavailability - % of dose that gets into body Bioequivalence - similarity.
Assessment Statements H.3.1 Draw and label a diagram showing a transverse section of the ileum as seen under a light microscope. H.3.2 Explain the structural.
Chapter 3: The Human Body. Body Cells  Form tissues  Tissues form Organs  Organs form Systems (e.g., digestive)  Turnover  Require nutrients.
Controlled Drug Delivery: From Macroformulation to Nanotechnology
Nanoparticulate drug delivery systems
College of Medicine and Public Health USDA & Nanotech Delivery of (Bio)molecules ? Mauro Ferrari, Ph.D. Associate Vice President, Health Sciences, Technology.
1 Controlled Release Introduction and Background.
Nanotechnology in Drug Delivery for Cancer Current Technologies
Overview  Founded in 2008  Privately held technology development company  Reorganized under new ownership as Tamarisk Technologies Group in 2014 About.
Drug Formulation / Drug Delivery Raj Suryanarayanan (Sury) Department of Pharmaceutics College of Pharmacy 1.
Pharmacokinetics Chapter 4.
Drug-Like Properties: Optimizing Pharmacokinetics and Safety During Drug Discovery Li Di and Edward H. Kerns ACS Short Course.
Absorption is the uptake of digested
UNIT 6: PHYSIOLOGY Chapter 32: Digestive and Excretory Systems.
 insulin and glucagon- Which regulate the level of glucose in the blood  Somatostatin- which prevents the release of the insulin and glucagon.
Chemistry of Living Things. Homeostasis: Homeostasis: A balanced state in an organism’s body. Failure to maintain homeostasis results in disease or death.
ERT 420 BIOPHARMACEUTICAL ENGINEERING ERT 420 BIOPHARMACEUTICAL ENGINEERING Semester 1 Academic Session 2012/2013 HUZAIRY HASSAN School Of Bioprocess Engineering.
Hydrogels in Drug Delivery Rassoul Dinarvand, PhD Professor of Pharmaceutics.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Transport through plasma membrane Physiology -I PHL 215 PHL 215 Dr/Gamal Gabr Pharmacy College Pharmacy College 1.
Membrane Transport Mechanisms in Industry and Medicine.
NANOTECHNOLOGIES: THE NEW GENERATION OF MEDICINE Dr Mariano Licciardi.
BioSensors Yang Yang 9/28/2004. Outlines BioMEMS Enzyme-coated carbon nanotubes Microcantilever biosensor with environmentally responsive hydrogel Cantilever.
What is bilirubin? What does it have to do with jaundice? Bilirubin is a protein-part that is left from the breakdown of hemoglobin by hepatocytes (liver.
AS/A-LEVEL BIOLOGY Protein digestion and absorption presentation
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Basic Pharmacokinetics The time course of drug action Collected and Prepared By S.Bohlooli, PhD.
Biomaterials, Drug Delivery, Nanotechnology and Bioengineering Nicholas A. Peppas Center for Biomaterials, Drug Delivery, Bionanotechnology and Molecular.
Controlled drug delivery Jonathan O’Dwyer John Rasmussen CHEN 641.
Absorption in the Small Intestines. IB Assessment Statement H.3.1 Draw and label a diagram showing a transverse section of the ileum as seen under a light.
BIOAVAILABILITY Time course of drug in the body: route of drug administration Oral vs IV injection Reasons for differences: completeness and rate of absorption.
Physiologic Factors consider systemic delivery
”Petru Poni” Institute of Macromolecular Chemistry Grigore Ghica Voda Alley No 41 A, Iasi, Romania Project No 254/ Code Project: PNII- RU-TE
Modular Nanodevices for Creation of Smart Adaptable Vaccine Delivery Vehicles Tarek M. Fahmy Dept. of Biomedical Engineering, Yale University Several key.
NASAL DELIVERY OF INSULIN.  Insulin is a peptide hormone composed of 51 amino acids & has molecular weight of 5808 Da  It is produced in the islets.
Drug Carrier Systems Targeted to Widely Dispersed Cells Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics KLE University College.
Goals: -Vitamins! -Role of accessory organs -Urinary system anatomy.
Nanotechnology in Medicine Krešimir Pavelić, Marijeta Kralj and Damir Kralj Division of Molecular Medicine and Division of Material Chemistry Ruđer.
2 Sylvia S. Mader Sylvia S. Mader Concepts of Biology © Zanichelli editore, 2012 Immagini e concetti della biologia.
A review: Using nanoparticles to enhance absorption and bioavailability of phenolic phytochemicals BILAL JAVED PhD BOTANY 09-ARID-1473 PMAS-ARID AGRICULTURE.
Methods and Materials Aldehyde Synthesis: The aldehyde was synthesized by oxidation of PEG dissolved in dichloromethane with sieves and NMO. TPAP was added.
PEG Hydrogel Coating for Medical Devices PEG Hydrogel Coating for Medical Devices B. Mulawka, B. Roedl, P. Schenk, D. Patel Advisor: Professor William.
Basic Principles: PK By: Alaina Darby.
Chapter 18.2a The Digestive System.
Biology Journal 12/4/2014 What’s the difference between an essential nutrient and a nonessential nutrient? Why are they both “nutrients”? Left: a consumer-guide.
Pharmacology I BMS 242 Lecture II (Continued)
CHAPTER 7 ABSORPTION KINETICS.
Intranasal Drug administration
Biopharmaceutics factors affecting Modified release products
Floating Drug Delivery System (FDDS)
BTY100-Lec 2.3 Nanobiotechnology.
Immagini e concetti della biologia Sylvia S. Mader
Pharmacology I BMS 242 Lecture II (Continued)
Unit 3: Biochemistry Part 1 Review
6.1 - Digestion.
Introduction; Scope of Pharmacology Routes of Drug Administration
6.1 - Digestion.
Rectal drug administration
Drug Delivery Systems Pharmaceutical technology Petra University.
Chapter 32: Digestive and Excretory Systems
Chapter 32: Digestive and Excretory Systems
Pharmacokinetics.
By JERLIN G. Research Scholar, Department of Physics.
Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells
Digestion Topic 6.1 (modified for 2016 exam).
AS Level Paper 1 and 2. A2 Level Paper 1 and 3 - Topics 1-4
Section 3.1: Biological Molecules Monomers and Polymers
Presentation transcript:

Intelligent Biomaterials Protein Delivery Molecular Imprinting and Micropatterning Nicholas A. Peppas

Our Laboratories 22 Researchers 12 Ph.D. students (8 ChEs, 4 BMEs) 3 Visiting scientists (Italy) 1 Technician 6 Undegraduate students About 3,800 sq.ft. facilities Modern equipment including cellular facilities Budget of about $ 2M Grants from NIH, NSF, industry

The Changing World of Biomaterials, Drug Delivery and Biomolecular Engineering Formation and fabrication of supramolecular assemblies comprising natural biological elements, structures or membranes. Synthesis and preparation of modified biological molecules Biomolecules as the basis of nanostructures, molecular adhesives Micropatterned and microfabricated arrays

Oral protein delivery

Oral Delivery of Proteins “Oral delivery of peptides and proteins has long been dubbed the ‘Holy Grail’ of drug delivery…” Why? Increase patient compliance and comfort over other forms of drug delivery (i.e. injection) Mimic physiologic delivery of proteins Simple administration Reduce costs Potentially improve efficacy

Challenges of Oral Protein Delivery GI Tract is designed to digest proteins and food. Protect the drug Acidic environment in the stomach Proteolytic enzymes in the GI tract Improve bioavailability Increase drug transport across intestinal epithelium Localize drug at targeted site of absorption Maintain biologically active and stable drug

Transport for Oral Drug Absorption Transport Mechanism Transcellular pathway Paracellular pathway Transcytosis and receptor-mediated endocytosis Lymphatic absorption through M cells P-glycoprotein efflux (not shown) Factors Affecting Transport Molecular mass of drug Drug solubility

In Vivo Study with pH-Responsive Complexation Hydrogels P(MAA-g-EG) microspheres loaded with insulin Administered to diabetic rats 40% drop in blood glucose levels Prior work done by Tony Lowman

Carrier Mediated Goal: Protect drug in the GI tract and be absorbed with drug by epithelial layer. Biodegradable polymers, lectin modified carriers Sites of uptake M cells (majority of uptake) Transcellular Paracellular Poor particle absorption Florence, A. T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res 1997, 3, 259-266.

Mucoadhesion Upper small Intestine Stomach Mucosa Mucosa Decomplexation Mucosa Mucosa

Blood Glucose Response in Healthy and Diabetic Wistar Rats

Caco-2 Cells as GI Model Spontaneously differentiate Produce enzymes Advantages Spontaneously differentiate Produce enzymes Posses tight junctions Develop microvilii Transport of inorganic molecules correlates well with the in vivo absorption Disadvantages Do not produce mucus The properties are determined by the passage number

Nanodevices of Intelligent Gels for Protein Release Empty hydrogel absorbs glucose leading to gluconic acid production I GOx I GOx I I I G GlucA GOx I G G I G I GlucA GOx G GlucA G I I GlucA GOx G G I G GOx Decrease in pH leads to gel expansion which releases insulin GlucA G I

Targetting and Nanotechnology Targeted delivery for cancer therapy Gene delivery Long term treatment of chronic diseases

BioMEMS Sensor Platform Pattern environmentally responsive hydrogels onto silicon microcantilevers to create a BioMEMS/MEMS sensor device. Polymer Silicon Laser beam θ φ > θ Laser beam φ Change in pH, temperature, etc.  hydrogel swells

Experimental Procedure Surface Modification Micropatterning

Micropatterned Hydrogel on Silicon Microcantilever Volume shrunk as the polymerization proceeded Polymer adhered to silicon surface and could not shrink at the interface, resulting in stress formation in the polymer film This stress in the polymer film resulted in bending the microcantilever A) B) Top view images obtained utilizing an optical microscope in Nomarski mode showing a silicon microcantilever patterned with an environmentally responsive hydrogel. In A), the focus is on the substrate, while in B), the focus is on the microcantilever tip. Profilometry indicated that the thickness of the patterned hydrogel is approximately 2.2 mm.

Confocal Images of Microarrays Acrylamide-PEG200DMA with 67% Crosslinking Ratio 3D Projection of micropatterned recatangular array of a biorecognitive networks obtained utilizing a confocal microscope. Profilometry indicated that the thickness of the micropatterns are approximately 13 mm.

Optical and Confocal Images of Micropatterns Acrylamide-PEG200DMA with 67% Crosslinking Ratio Microcantilever Shape B) 25 m Control C) Recognitive 50 m Silicon Polymer A) Images of micropatterned biorecognitive networks. In A), an optical image (Nomarski mode) of recognitive network patterned in shape of cantilever is demonstrated. In B) and C), a confocal microscope slice through middle cantilever pattern of a control and recognitive network, respectively, are shown. Profilometry indicated that the thickness of the micropatterns are approximately 13 mm.